GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ferozsons Laboratories Ltd (KAR:FEROZ) » Definitions » EV-to-EBITDA

Ferozsons Laboratories (KAR:FEROZ) EV-to-EBITDA : 6.91 (As of Jun. 03, 2025)


View and export this data going back to 1960. Start your Free Trial

What is Ferozsons Laboratories EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ferozsons Laboratories's enterprise value is ₨18,786 Mil. Ferozsons Laboratories's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was ₨2,720 Mil. Therefore, Ferozsons Laboratories's EV-to-EBITDA for today is 6.91.

The historical rank and industry rank for Ferozsons Laboratories's EV-to-EBITDA or its related term are showing as below:

KAR:FEROZ' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.25   Med: 7.93   Max: 15.74
Current: 6.9

During the past 10 years, the highest EV-to-EBITDA of Ferozsons Laboratories was 15.74. The lowest was 2.25. And the median was 7.93.

KAR:FEROZ's EV-to-EBITDA is ranked better than
78.64% of 735 companies
in the Drug Manufacturers industry
Industry Median: 14.16 vs KAR:FEROZ: 6.90

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-03), Ferozsons Laboratories's stock price is ₨335.62. Ferozsons Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₨17.340. Therefore, Ferozsons Laboratories's PE Ratio (TTM) for today is 19.36.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Ferozsons Laboratories EV-to-EBITDA Historical Data

The historical data trend for Ferozsons Laboratories's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ferozsons Laboratories EV-to-EBITDA Chart

Ferozsons Laboratories Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.62 5.81 5.74 7.41 6.58

Ferozsons Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.64 6.58 6.61 7.07 6.47

Competitive Comparison of Ferozsons Laboratories's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Ferozsons Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ferozsons Laboratories's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ferozsons Laboratories's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ferozsons Laboratories's EV-to-EBITDA falls into.


;
;

Ferozsons Laboratories EV-to-EBITDA Calculation

Ferozsons Laboratories's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=18786.118/2720.17
=6.91

Ferozsons Laboratories's current Enterprise Value is ₨18,786 Mil.
Ferozsons Laboratories's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨2,720 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ferozsons Laboratories  (KAR:FEROZ) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Ferozsons Laboratories's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=335.62/17.340
=19.36

Ferozsons Laboratories's share price for today is ₨335.62.
Ferozsons Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨17.340.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Ferozsons Laboratories EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ferozsons Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Ferozsons Laboratories Business Description

Traded in Other Exchanges
N/A
Address
5.K.M - Sunder Raiwind Road, Lahore, PB, PAK
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and oncology. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. It operates in three segments namely Ferozsons; BF Biosciences; and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.

Ferozsons Laboratories Headlines

No Headlines